Use of arsenic trioxide as an antivascular and thermosensitizing agent in solid tumors

Neoplasia

Volumn 2, Issue 6, 2000, Pages 555-560

  Griffin, Robert J ^a   Lee, Sang H ^a   Rood, Kelly L ^a   Stewart, Michael J ^a   Lyons, John C ^a   Lew, Young S ^b   Park, Heonjoo ^a   Song, Chang W ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b HENRY FORD HEALTH SYSTEM   (United States)

Author keywords

Adhesion molecules; Arsenic trioxide; Thermosensitization; Tumor perfusion

Indexed keywords

ARSENIC TRIOXIDE; CELL ADHESION MOLECULE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; HEAT SENSITIVITY; HYPERTHERMIA; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NONHUMAN; PERFUSION; PRIORITY JOURNAL; SOLID TUMOR;

ANGIOGENESIS INHIBITORS; ANIMALS; ANTINEOPLASTIC AGENTS; ARSENICALS; E-SELECTIN; FEMALE; FIBROSARCOMA; HYPERTHERMIA, INDUCED; IMMUNOHISTOCHEMISTRY; INTERCELLULAR ADHESION MOLECULE-1; MALE; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED A; MICE, INBRED C3H; NEOVASCULARIZATION, PATHOLOGIC; OXIDES; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR CELL ADHESION MOLECULE-1;

EID: 0034490275     PISSN: 15228002     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.neo.7900123     Document Type: Article

References (30)

1. A history of the use of arsenicals in man
2. Arsenic - New life for an old potion
3. Chelators and heavy metal intoxication
4. History of the treatment of chronic myelocytic leukemia
5. Ai-Lin I treated 32 cases of acute promyelocytic leukemia
6. Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide
7. 3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients
8. Arsenic trioxide as an inducer of apoptosis and loss of PML/RARα protein in acute promyelocytic leukemia cells
9. Arsenic trioxide causes selective necrosis in solid murine tumors by vascular shutdown
10. Tumor temperature distributions predict hyperthermia effect
11. Relationship between thermal dose and outcome in thermoradiotherapy treatments for superficial recurrences of breast cancer: Data from a phase III trial
12. Regional blood flow by fractional distribution of indicators
13. Inhibition of vascular endothelial growth factor-induced angiogenesis suppressed tumor growth in vivo
14. Angiogenesis
15. Improvement of tumor oxygenation status by mild temperature hyperthermia alone or in combination with carbogen
16. Arsenic poisoning
17. Cytoprotective effect of reduced glutathione in arsenical-induced endothelial cell injury
18. Enhancement of cytotoxicity of hydrogen peroxide by hyperthermia in chinese hamster ovary cells: Role of antioxidant defenses
19. Inhibition of antioxidants and hyperthermia enhance bleomycin-induced cytotoxicity and lipid peroxidation in chinese hamster ovary cells
20. Oxidative stress precedes circulatory failure induced by 35-GHz microwave heating
21. Theoretical feasibility of vasodilator enhanced local tumor heating
22. Hyperthermia increases intercellular adhesion molecule-1 expression and lymphocyte adhesion to endothelial cells
23. Effects of hyperthermia and tumour necrosis factor on inflammatory cytokine secretion and procoagulant activity in endothelial cells
24. Effects of hydralazine on the blood flow in tumors and normal tissues of rats
25. Interleukin-1α-induced tumour pathophysiologies can be exploited with bioreductive alkylating agents
26. Flavone acetic acid: Is vascular shutdown the crucial mechanism of action?
27. A novel drug to reduce tumor perfusion: Antitumor effect alone and with hyperthermia
28. Combretastatin A-4 phosphate as a tumor vascular-targeting agent: Early effects in tumors and normal tissues
29. Induction of apoptosis in proliferating human endothelial cells by the tumor-specific antiangiogenesis agent combretastatin A-4
30. Combretastatin A-4, an agent that displays potent and selective toxicity toward tumor vasculature